Process for controlling crystal structure of risedronate

Details for Australian Patent Application No. 2004261561 (hide)

Owner The Procter & Gamble Company

Inventors Godlewski, Jane Ellen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004261561

PCT Pub. Number WO2005/012314

Priority 60/491,222 30.07.03 US

Filing date 15 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 26 June 2008

International Classifications

C07F 9/58 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012314 Priority application(s): WO2005/012314

26 June 2008 Application Accepted

  Published as AU-B-2004261561

23 October 2008 Standard Patent Sealed

18 February 2010 Assignment Registered

  The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261567-Process for the preparation of cPLA2 inhibitors

2004261560-Metal containers having an easily openable end and method of manufacturing the same